Indica Labs, an industry leader in quantitative digital pathology and image management solutions, and Ibex Medical Analytics, a pioneer in artificial intelligence (AI)-based cancer diagnostics, announced an agreement to integrate the Galen AI-based cancer diagnostics platform into the HALO AP digital pathology workflow platform.

The HALO AP platform was developed by Indica Labs to address the needs of digital anatomic pathology labs. The platform can be fully integrated within existing LIS or HIS solutions or can operate as a standalone case and image management system for anatomic pathology. Furthermore, HALO AP supports a full range of tissue-based assays and workflows, including synoptic reporting, tumour boards, secondary consults, quantitative analysis, and AI-assisted workflows. HALO AP is used by some of the largest anatomic pathology laboratories in the world, including NeoGenomics and the National Cancer Institute (NCI).

Ibex’s Galen platform uses strong AI algorithms that support pathologists in improving the quality of cancer diagnosis and providing productivity-enhancing insights that help reduce turnaround times.